Active Mycobacterium Infection Due to Intramuscular BCG Administration Following Multi-Steps Medication Errors
Bacillus Calmette-Guérin (BCG) is indicated for treatment of primary or relapsing flat urothelial cell carcinoma in situ (CIS) of the urinary bladder. Disseminated infectious complications occasionally occur due to BCG as a vaccine and intravesical therapy. Intramuscular (IM) or Intravenous (IV) ad...
Saved in:
Main Authors: | MohammadReza Rafati (Author), Bizhan Kouchaki (Author) |
---|---|
Format: | Book |
Published: |
Research Center for Rational Use of Drugs (RCRUD),
2015-10-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Multi-stage subunit vaccines against Mycobacterium tuberculosis: an alternative to the BCG vaccine or a BCG-prime boost?
by: Farzad Khademi, et al.
Published: (2018) -
BCG-mediated protection against Mycobacterium ulcerans infection in the mouse.
by: Paul J Converse, et al.
Published: (2011) -
Optimisation of <i>Mycobacterium bovis</i> BCG Fermentation and Storage Survival
by: Jordan Pascoe, et al.
Published: (2020) -
Doença de Pott após tratamento intravesical com Mycobacterium bovis BCG
by: Samaher Tannira, et al.
Published: (2016) -
High Mobility Group Box 1 Protein Induction by Mycobacterium Bovis BCG
by: Péter Hofner, et al.
Published: (2007)